The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)



Gene Review

MMP25  -  matrix metallopeptidase 25

Homo sapiens

Synonyms: Leukolysin, MMP-25, MMP20, MMP20A, MMPL1, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of MMP25

  • Taken these facts together, we conclude that MT6-MMP may participate in tumor invasion and metastasis by directly converting proMMP-2 into active form [1].
  • On the basis of these results, we propose that MT6-MMP may facilitate tumor progression through its ability to activate progelatinase A at the membrane of cells from colon carcinomas or brain tumors [2].
  • MT6-MMP was also detected at high levels in SW480 colon carcinoma cells as well as in some anaplastic astrocytomas and glioblastomas, but not in normal colon or brain or in meningiomas [2].
  • These results show that MT6-MMP may play a role in colon cancer and exhibit unique biochemical and structural properties that may regulate proteolytic function at the cell surface [3].

High impact information on MMP25

  • Using the catalytically inactive mutant MMP-2EA (the E404A mutant of proMMP-2), which cannot autocatalytically mature from the intermediate form into the mature one, we show that MT6-MMP cleaves not only the known MT-MMP-processing site at Asn(66)-Leu but also the previously unsuspected Asn(109)-Tyr to yield a fully mature molecule [1].
  • Despite their difference in mediating proMMP-2 activation in transfected cells, the CAT of MT6-MMP appears to be as efficient as that of MT5-MMP in cleaving proMMP-2EA in buffer, suggesting that its CAT is a strong proMMP-2 activator [1].
  • Based on these properties, this novel human matrix metalloproteinase has been called MT6-MMP because it is the sixth identified member of this subfamily of matrix metalloproteinase [2].
  • Northern blot analysis of polyadenylated RNAs isolated from human tissues demonstrated that MT6-MMP is predominantly expressed in leukocytes, lung, and spleen [2].
  • Cotransfection of expression plasmids encoding MT6-MMP and progelatinase A resulted in activation of COS-7-secreted progelatinase A, as demonstrated by gelatin zymography [2].

Biological context of MMP25


Anatomical context of MMP25


Associations of MMP25 with chemical compounds

  • In addition, phosphatidyl inositol-specific phospholipase C treatment released MT6-MMP from the surface of transfected cells [8].
  • Here, we show that alpha-1-proteinase inhibitor, or alpha1-PI, a known protective shield against destructive serine proteinases, is a physiological target for leukolysin [9].

Other interactions of MMP25

  • The enzyme activity of the soluble MT6-MMP was inactive in the clusterin complex [5].
  • Mature and soluble MT6-MMP processed at the furin motif was purified as a 45-kDa protein together with a 46-kDa protein having a single cleavage in the hemopexin-like domain [5].
  • Our results showed that MT6-MMP as well as MT4-MMP were labeled with [3H]ethanolamine indicating the presence of a GPI unit with incorporated label [8].
  • The proteolytic activity of MT6-MMP has been studied using recombinant catalytic fragments and shown to degrade several components of the extracellular matrix [5].
  • Thus, we tested the possibility that MT6-MMP was also a GPI-anchored proteinase [8].

Analytical, diagnostic and therapeutic context of MMP25


  1. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond. Nie, J., Pei, D. Cancer Res. (2003) [Pubmed]
  2. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Velasco, G., Cal, S., Merlos-Suárez, A., Ferrando, A.A., Alvarez, S., Nakano, A., Arribas, J., López-Otín, C. Cancer Res. (2000) [Pubmed]
  3. MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties. Sun, Q., Weber, C.R., Sohail, A., Bernardo, M.M., Toth, M., Zhao, H., Turner, J.R., Fridman, R. J. Biol. Chem. (2007) [Pubmed]
  4. The localization of matrix metalloproteinase-20 (MMP-20, enamelysin) in mature human teeth. Sulkala, M., Larmas, M., Sorsa, T., Salo, T., Tjäderhane, L. J. Dent. Res. (2002) [Pubmed]
  5. Clusterin, an abundant serum factor, is a possible negative regulator of MT6-MMP/MMP-25 produced by neutrophils. Matsuda, A., Itoh, Y., Koshikawa, N., Akizawa, T., Yana, I., Seiki, M. J. Biol. Chem. (2003) [Pubmed]
  6. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25). English, W.R., Velasco, G., Stracke, J.O., Knäuper, V., Murphy, G. FEBS Lett. (2001) [Pubmed]
  7. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Pei, D. Cell Res. (1999) [Pubmed]
  8. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. Kojima, S., Itoh, Y., Matsumoto, S., Masuho, Y., Seiki, M. FEBS Lett. (2000) [Pubmed]
  9. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. Nie, J., Pei, D. Exp. Cell Res. (2004) [Pubmed]
  10. Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells. Grant, G.M., Giambernardi, T.A., Grant, A.M., Klebe, R.J. Matrix Biol. (1999) [Pubmed]
WikiGenes - Universities